Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.1B | 8.2B | 7.9B | 8.2B |
| Cost of revenue | 7.0B | 7.1B | 6.8B | 7.0B |
| Gross profit | 1.1B | 1.1B | 1.0B | 1.1B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 1.0B | 1.0B | 1.0B | 1.1B |
| Operating income | 57M | 41M | 23M | 41M |
| Non operating interest income | ||||
| Income | 1M | 0 | 1M | 1M |
| Expense | 35M | 37M | 35M | 39M |
| Other income expense | -37M | -8M | -11M | -45M |
| Pretax income | -16M | -5M | -24M | -44M |
| Tax provision | -9M | -3M | -4M | -7M |
| Net income | -7M | -2M | -20M | -37M |
| Basic EPS | -0.1 | -0.1 | -0.4 | -0.6 |
| Diluted EPS | -0.1 | -0.1 | -0.4 | -0.6 |
| Basic average shares | 60.5M | 60.2M | 59.6M | 59.5M |
| Diluted average shares | 60.5M | 60.2M | 59.6M | 59.5M |
| EBITDA | 142M | 127M | 109M | 135M |
| Net income from continuing op. | -7M | -2M | -20M | -37M |
| Minority interests | 0 | -1M | -1M | 0 |
| Preferred stock dividends | — | — | — | — |